The response against NSCLC in the only NSCLC patient in the trial was not such a surprise . A few years back Rational Therapeutics of L.A. independently tested SBP002 on NSCLC . Nice to see the first verification of his results .
When you consider that these tests were done on fresh tumour human samples ex-vivo , without the extra advantage provided by the now proven immune system boost , the results are extraordinary . I believe Rational Therapeutics are currently conducting further tests to refine which cancers are the best targets for ongoing Phase 2 trials . Cheers
SBP Price at posting:
0.0¢ Sentiment: None Disclosure: Not Held
